Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 88

1.

Readmission and death following hospitalization among people with HIV in South Africa.

Hoffmann CJ, Milovanovic M, Cichowitz C, Kinghorn A, Martinson NA, Variava E.

PLoS One. 2019 Jul 3;14(7):e0218902. doi: 10.1371/journal.pone.0218902. eCollection 2019.

2.

"It's Not Like Taking Chocolates": Factors Influencing the Feasibility and Sustainability of Universal Test and Treat in Correctional Health Systems in Zambia and South Africa.

Topp SM, Chetty-Makkan CM, Smith HJ, Chimoyi L, Hoffmann CJ, Fielding K, Reid SE, Olivier AJ, Hausler H, Herce ME, Charalambous S.

Glob Health Sci Pract. 2019 Jun 27;7(2):189-202. doi: 10.9745/GHSP-D-19-00051. Print 2019 Jun.

3.

Re-thinking Linkage to Care in the Era of Universal Test and Treat: Insights from Implementation and Behavioral Science for Achieving the Second 90.

Herce ME, Chi BH, Liao RC, Hoffmann CJ.

AIDS Behav. 2019 Jun 3. doi: 10.1007/s10461-019-02541-5. [Epub ahead of print]

PMID:
31161462
4.

Refining humane endpoints in mouse models of disease by systematic review and machine learning-based endpoint definition.

Mei J, Banneke S, Lips J, Kuffner MTC, Hoffmann CJ, Dirnagl U, Endres M, Harms C, Emmrich JV.

ALTEX. 2019 Apr 18. doi: 10.14573/altex.1812231. [Epub ahead of print]

5.

Men's perceptions of HIV care engagement at the facility- and provider-levels: Experiences in Cote d'Ivoire.

Tibbels NJ, Hendrickson ZM, Naugle DA, Dosso A, Van Lith L, Mallalieu EC, Kouadio AM, Kra W, Kamara D, Dailly-Ajavon P, Cisse A, Seifert-Ahanda K, Thaddeus S, Babalola S, Hoffmann CJ.

PLoS One. 2019 Mar 21;14(3):e0211385. doi: 10.1371/journal.pone.0211385. eCollection 2019.

6.

Hospitalization and post-discharge care in South Africa: A critical event in the continuum of care.

Cichowitz C, Pellegrino R, Motlhaoleng K, Martinson NA, Variava E, Hoffmann CJ.

PLoS One. 2018 Dec 13;13(12):e0208429. doi: 10.1371/journal.pone.0208429. eCollection 2018.

7.

Enhancing value and lowering costs of care: a qualitative exploration of a randomized linkage to care intervention in South Africa.

Jain K, Mshweshwe-Pakela NT, Charalambous S, Mabuto T, Hoffmann CJ.

AIDS Care. 2019 Apr;31(4):481-488. doi: 10.1080/09540121.2018.1503636. Epub 2018 Aug 5.

PMID:
30078352
8.

Value stream mapping to characterize value and waste associated with accessing HIV care in South Africa.

Hoffmann CJ, Milovanovic M, Kinghorn A, Kim HY, Motlhaoleng K, Martinson NA, Variava E.

PLoS One. 2018 Jul 24;13(7):e0201032. doi: 10.1371/journal.pone.0201032. eCollection 2018.

9.

Using mHealth to improve tuberculosis case identification and treatment initiation in South Africa: Results from a pilot study.

Maraba N, Hoffmann CJ, Chihota VN, Chang LW, Ismail N, Candy S, Madibogo E, Katzwinkel M, Churchyard GJ, McCarthy K.

PLoS One. 2018 Jul 3;13(7):e0199687. doi: 10.1371/journal.pone.0199687. eCollection 2018.

10.

Including the criminal justice-involved at the HIV policy, research and service delivery table.

Ndlovu DT, Hoffmann CJ.

J Int AIDS Soc. 2018 Jun;21(6):e25145. doi: 10.1002/jia2.25145. No abstract available.

11.

Perceptions of Value and Cost of HIV Care Engagement Following Diagnosis in South Africa.

Mabuto T, Charalambous S, Kennedy C, Hoffmann CJ.

AIDS Behav. 2018 Nov;22(11):3751-3762. doi: 10.1007/s10461-018-2089-2.

PMID:
29556834
12.

Depression and alcohol use disorder at antiretroviral therapy initiation led to disengagement from care in South Africa.

Cichowitz C, Maraba N, Hamilton R, Charalambous S, Hoffmann CJ.

PLoS One. 2017 Dec 27;12(12):e0189820. doi: 10.1371/journal.pone.0189820. eCollection 2017.

13.

Brief Report: Assessing the Association Between Changing NRTIs When Initiating Second-Line ART and Treatment Outcomes.

Rohr JK, Ive P, Horsburgh CR, Berhanu R, Hoffmann CJ, Wood R, Boulle A, Giddy J, Prozesky H, Vinikoor M, Mwanza MW, Wandeler G, Davies MA, Fox MP.

J Acquir Immune Defic Syndr. 2018 Apr 1;77(4):413-416. doi: 10.1097/QAI.0000000000001611.

14.

Plasma Indoleamine 2, 3-Dioxygenase, a Biomarker for Tuberculosis in Human Immunodeficiency Virus-Infected Patients.

Adu-Gyamfi CG, Snyman T, Hoffmann CJ, Martinson NA, Chaisson RE, George JA, Suchard MS.

Clin Infect Dis. 2017 Oct 15;65(8):1356-1358. doi: 10.1093/cid/cix550.

15.

Factors Associated With Poor Linkage to HIV Care in South Africa: Secondary Analysis of Data From the Thol'impilo Trial.

Dorward J, Mabuto T, Charalambous S, Fielding KL, Hoffmann CJ.

J Acquir Immune Defic Syndr. 2017 Dec 15;76(5):453-460. doi: 10.1097/QAI.0000000000001550.

PMID:
28961678
16.

Factors associated with pulmonary impairment in HIV-infected South African adults.

Gupte AN, Wong ML, Msandiwa R, Barnes GL, Golub J, Chaisson RE, Hoffmann CJ, Martinson NA.

PLoS One. 2017 Sep 13;12(9):e0184530. doi: 10.1371/journal.pone.0184530. eCollection 2017.

17.

Strategies to Accelerate HIV Care and Antiretroviral Therapy Initiation After HIV Diagnosis: A Randomized Trial.

Hoffmann CJ, Mabuto T, Ginindza S, Fielding KL, Kubeka G, Dowdy DW, Churchyard GJ, Charalambous S.

J Acquir Immune Defic Syndr. 2017 Aug 15;75(5):540-547. doi: 10.1097/QAI.0000000000001428.

18.

Mutational Correlates of Virological Failure in Individuals Receiving a WHO-Recommended Tenofovir-Containing First-Line Regimen: An International Collaboration.

Rhee SY, Varghese V, Holmes SP, Van Zyl GU, Steegen K, Boyd MA, Cooper DA, Nsanzimana S, Saravanan S, Charpentier C, de Oliveira T, Etiebet MA, Garcia F, Goedhals D, Gomes P, Günthard HF, Hamers RL, Hoffmann CJ, Hunt G, Jiamsakul A, Kaleebu P, Kanki P, Kantor R, Kerschberger B, Marconi VC, D'amour Ndahimana J, Ndembi N, Ngo-Giang-Huong N, Rokx C, Santoro MM, Schapiro JM, Schmidt D, Seu L, Sigaloff KCE, Sirivichayakul S, Skhosana L, Sunpath H, Tang M, Yang C, Carmona S, Gupta RK, Shafer RW.

EBioMedicine. 2017 Apr;18:225-235. doi: 10.1016/j.ebiom.2017.03.024. Epub 2017 Mar 19.

19.

Impact of Antiretroviral Therapy on Liver Fibrosis Among Human Immunodeficiency Virus-Infected Adults With and Without HBV Coinfection in Zambia.

Vinikoor MJ, Sinkala E, Chilengi R, Mulenga LB, Chi BH, Zyambo Z, Hoffmann CJ, Saag MS, Davies MA, Egger M, Wandeler G; IeDEA- Southern Africa.

Clin Infect Dis. 2017 May 15;64(10):1343-1349. doi: 10.1093/cid/cix122. Erratum in: Clin Infect Dis. 2017 Oct 15;65(8):1431-1433.

20.

Effective Interpersonal Health Communication for Linkage to Care After HIV Diagnosis in South Africa.

Mabuto T, Charalambous S, Hoffmann CJ.

J Acquir Immune Defic Syndr. 2017 Jan 1;74 Suppl 1:S23-S28.

21.

Occult HIV-1 drug resistance to thymidine analogues following failure of first-line tenofovir combined with a cytosine analogue and nevirapine or efavirenz in sub Saharan Africa: a retrospective multi-centre cohort study.

Gregson J, Kaleebu P, Marconi VC, van Vuuren C, Ndembi N, Hamers RL, Kanki P, Hoffmann CJ, Lockman S, Pillay D, de Oliveira T, Clumeck N, Hunt G, Kerschberger B, Shafer RW, Yang C, Raizes E, Kantor R, Gupta RK.

Lancet Infect Dis. 2017 Mar;17(3):296-304. doi: 10.1016/S1473-3099(16)30469-8. Epub 2016 Dec 1.

22.

Retention and mortality outcomes from a community-supported public-private HIV treatment programme in Myanmar.

Mburu G, Paing AZ, Myint NN, Di W, Thu KH, Ram M, Hoffmann CJ, Wang B, Naing S.

J Int AIDS Soc. 2016 Oct 25;19(1):20926. doi: 10.7448/IAS.19.1.20926. eCollection 2016.

23.

Life expectancy trends in adults on antiretroviral treatment in South Africa.

Johnson LF, Keiser O, Fox MP, Tanser F, Cornell M, Hoffmann CJ, Prozesky H, Boulle A, Davies MA; International Epidemiologic Databases to Evaluate AIDS Southern Africa (IeDEA-SA) Collaboration.

AIDS. 2016 Oct 23;30(16):2545-2550.

24.

Passive Entrapment of Tumor Cells Determines Metastatic Dissemination to Spinal Bone and Other Osseous Tissues.

Broggini T, Piffko A, Hoffmann CJ, Harms C, Vajkoczy P, Czabanka M.

PLoS One. 2016 Sep 7;11(9):e0162540. doi: 10.1371/journal.pone.0162540. eCollection 2016.

25.

A Framework to Inform Strategies to Improve the HIV Care Continuum in Low- and Middle-Income Countries.

Hoffmann CJ, Mabuto T, McCarthy K, Maulsby C, Holtgrave DR.

AIDS Educ Prev. 2016 Aug;28(4):351-64. doi: 10.1521/aeap.2016.28.4.351.

PMID:
27427929
26.

HIV and tuberculosis in prisons in sub-Saharan Africa.

Telisinghe L, Charalambous S, Topp SM, Herce ME, Hoffmann CJ, Barron P, Schouten EJ, Jahn A, Zachariah R, Harries AD, Beyrer C, Amon JJ.

Lancet. 2016 Sep 17;388(10050):1215-27. doi: 10.1016/S0140-6736(16)30578-5. Epub 2016 Jul 14. Review.

27.

Household HIV Testing Uptake among Contacts of TB Patients in South Africa.

Velen K, Lewis JJ, Charalambous S, Page-Shipp L, Popane F, Churchyard GJ, Hoffmann CJ.

PLoS One. 2016 May 19;11(5):e0155688. doi: 10.1371/journal.pone.0155688. eCollection 2016.

28.

[S2k-guideline Helicobacter pylori and gastroduodenal ulcer disease].

Fischbach W, Malfertheiner P, Lynen Jansen P, Bolten W, Bornschein J, Buderus S, Glocker E, Hoffmann CJ, Koletzko S, Labenz J, Mayerle J, Miehlke S, Mössner J, Peitz U, Prinz C, Selgrad M, Suerbaum S, Venerito M, Vieth M; Verantwortlich für die DGVS.

Z Gastroenterol. 2016 Apr;54(4):1. doi: 10.1055/s-0035-1567086. Epub 2016 May 11. German.

29.

Hepatitis B Infection, Viral Load and Resistance in HIV-Infected Patients in Mozambique and Zambia.

Wandeler G, Musukuma K, Zürcher S, Vinikoor MJ, Llenas-García J, Aly MM, Mulenga L, Chi BH, Ehmer J, Hobbins MA, Bolton-Moore C, Hoffmann CJ, Egger M; IeDEA-Southern Africa.

PLoS One. 2016 Mar 31;11(3):e0152043. doi: 10.1371/journal.pone.0152043. eCollection 2016.

30.

Chronic hepatitis B increases mortality and complexity among HIV-coinfected patients in South Africa: a cohort study.

Velen K, Charalambous S, Innes C, Churchyard GJ, Hoffmann CJ.

HIV Med. 2016 Oct;17(9):702-7. doi: 10.1111/hiv.12367. Epub 2016 Mar 17.

31.

Hepatitis B prevalence and treatment needs among Tibetan refugees residing in India.

Stevens K, Palmo T, Wangchuk T, Solomon S, Dierberg K, Hoffmann CJ.

J Med Virol. 2016 Aug;88(8):1357-63. doi: 10.1002/jmv.24488. Epub 2016 Feb 8.

PMID:
26822932
32.

A comparison of death recording by health centres and civil registration in South Africans receiving antiretroviral treatment.

Johnson LF, Dorrington RE, Laubscher R, Hoffmann CJ, Wood R, Fox MP, Cornell M, Schomaker M, Prozesky H, Tanser F, Davies MA, Boulle A; International Epidemiologic Databases to Evaluate AIDS Southern Africa (IeDEA-SA) Collaboration.

J Int AIDS Soc. 2015 Dec 16;18:20628. doi: 10.7448/IAS.18.1.20628. eCollection 2015.

33.

CD4 count-based failure criteria combined with viral load monitoring may trigger worse switch decisions than viral load monitoring alone.

Hoffmann CJ, Maritz J, van Zyl GU.

Trop Med Int Health. 2016 Feb;21(2):219-23. doi: 10.1111/tmi.12639. Epub 2015 Dec 10.

34.

Implementation and Operational Research: Risk Charts to Guide Targeted HIV-1 Viral Load Monitoring of ART: Development and Validation in Patients From Resource-Limited Settings.

Koller M, Fatti G, Chi BH, Keiser O, Hoffmann CJ, Wood R, Prozesky H, Stinson K, Giddy J, Mutevedzi P, Fox MP, Law M, Boulle A, Egger M.

J Acquir Immune Defic Syndr. 2015 Nov 1;70(3):e110-9. doi: 10.1097/QAI.0000000000000748.

35.

Monitoring and switching of first-line antiretroviral therapy in adult treatment cohorts in sub-Saharan Africa: collaborative analysis.

Haas AD, Keiser O, Balestre E, Brown S, Bissagnene E, Chimbetete C, Dabis F, Davies MA, Hoffmann CJ, Oyaro P, Parkes-Ratanshi R, Reynolds SJ, Sikazwe I, Wools-Kaloustian K, Zannou DM, Wandeler G, Egger M; IeDEA southern Africa, east Africa, and west Africa.

Lancet HIV. 2015 Jul;2(7):e271-8. doi: 10.1016/S2352-3018(15)00087-9. Epub 2015 Jun 16.

36.

Determinants of Weight Evolution Among HIV-Positive Patients Initiating Antiretroviral Treatment in Low-Resource Settings.

Huisin ʼt Veld D, Balestre E, Buyze J, Menten J, Jaquet A, Cooper DA, Dabis F, Yiannoutsos CT, Diero L, Mutevedzi P, Fox MP, Messou E, Hoffmann CJ, Prozesky HW, Egger M, Hemingway-Foday JJ, Colebunders R; International Epidemiologic Databases to Evaluate AIDS (IeDEA).

J Acquir Immune Defic Syndr. 2015 Oct 1;70(2):146-54. doi: 10.1097/QAI.0000000000000691.

37.

Treatment Failure, Drug Resistance, and CD4 T-Cell Count Decline Among Postpartum Women on Antiretroviral Therapy in South Africa.

Hoffmann CJ, Cohn S, Mashabela F, Hoffmann JD, McIlleron H, Denti P, Haas DW, Dooley KE, Martinson NA, Chaisson RE.

J Acquir Immune Defic Syndr. 2016 Jan 1;71(1):31-7. doi: 10.1097/QAI.0000000000000811.

38.

The HIV/HBV co-infected patient: Time for proactive management.

Andersson MI, Preiser W, Van Rensburg C, Taljaard J, Hoffmann CJ.

S Afr Med J. 2015 Apr;105(4):281-2. No abstract available.

PMID:
26294869
39.

Simultaneous Treatment of Missing Data and Measurement Error in HIV Research Using Multiple Overimputation.

Schomaker M, Hogger S, Johnson LF, Hoffmann CJ, Bärnighausen T, Heumann C.

Epidemiology. 2015 Sep;26(5):628-36. doi: 10.1097/EDE.0000000000000334.

40.

Implementing a large-scale systematic tuberculosis screening program in correctional facilities in South Africa.

Zishiri V, Charalambous S, Shah MR, Chihota V, Page-Shipp L, Churchyard GJ, Hoffmann CJ.

Open Forum Infect Dis. 2015 Jan 8;2(1):ofu121. doi: 10.1093/ofid/ofu121. eCollection 2015 Jan.

41.

Tuberculosis active case finding: uptake and diagnostic yield among minibus drivers in urban South Africa.

Mabuto T, Zwane E, Chihota V, Gresak G, Charalambous S, Churchyard GJ, Hoffmann CJ.

BMC Public Health. 2015 Mar 14;15:242. doi: 10.1186/s12889-015-1592-x.

42.

Evaluation of a point-of-care tuberculosis test-and-treat algorithm on early mortality in people with HIV accessing antiretroviral therapy (TB Fast Track study): study protocol for a cluster randomised controlled trial.

Fielding KL, Charalambous S, Hoffmann CJ, Johnson S, Tlali M, Dorman SE, Vassall A, Churchyard GJ, Grant AD.

Trials. 2015 Mar 28;16:125. doi: 10.1186/s13063-015-0650-0.

43.

Vascular signal transducer and activator of transcription-3 promotes angiogenesis and neuroplasticity long-term after stroke.

Hoffmann CJ, Harms U, Rex A, Szulzewsky F, Wolf SA, Grittner U, Lättig-Tünnemann G, Sendtner M, Kettenmann H, Dirnagl U, Endres M, Harms C.

Circulation. 2015 May 19;131(20):1772-82. doi: 10.1161/CIRCULATIONAHA.114.013003. Epub 2015 Mar 20.

PMID:
25794850
44.

Tuberculosis and hepatic steatosis are prevalent liver pathology findings among HIV-infected patients in South Africa.

Hoffmann CJ, Hoffmann JD, Kensler C, van der Watt M, Omar T, Chaisson RE, Martinson NA, Variava E.

PLoS One. 2015 Feb 10;10(2):e0117813. doi: 10.1371/journal.pone.0117813. eCollection 2015.

45.

Pooling sputum from multiple individuals for Xpert® MTB/RIF testing: a strategy for screening high-risk populations.

Zishiri V, Chihota V, McCarthy K, Charalambous S, Churchyard GJ, Hoffmann CJ.

Int J Tuberc Lung Dis. 2015 Jan;19(1):87-90. doi: 10.5588/ijtld.14.0372.

PMID:
25519796
46.

Rationale and evidence for human immunodeficiency virus treatment as prevention at the individual and population levels.

Hoffmann CJ, Gallant JE.

Infect Dis Clin North Am. 2014 Dec;28(4):549-61. doi: 10.1016/j.idc.2014.08.003. Epub 2014 Oct 5. Review.

PMID:
25287588
47.

Four models of HIV counseling and testing: utilization and test results in South Africa.

Mabuto T, Latka MH, Kuwane B, Churchyard GJ, Charalambous S, Hoffmann CJ.

PLoS One. 2014 Jul 11;9(7):e102267. doi: 10.1371/journal.pone.0102267. eCollection 2014.

48.

Maternal hepatitis B and infant infection among pregnant women living with HIV in South Africa.

Hoffmann CJ, Mashabela F, Cohn S, Hoffmann JD, Lala S, Martinson NA, Chaisson RE.

J Int AIDS Soc. 2014 May 22;17:18871. doi: 10.7448/IAS.17.1.18871. eCollection 2014.

49.

Durable HIV RNA resuppression after virologic failure while remaining on a first-line regimen: a cohort study.

Hoffmann CJ, Charalambous S, Grant AD, Morris L, Churchyard GJ, Chaisson RE.

Trop Med Int Health. 2014 Feb;19(2):236-9.

50.

Cotrimoxazole prophylaxis and tuberculosis risk among people living with HIV.

Hoffmann CJ, Chaisson RE, Martinson NA.

PLoS One. 2014 Jan 8;9(1):e83750. doi: 10.1371/journal.pone.0083750. eCollection 2014.

Supplemental Content

Loading ...
Support Center